Expressing support for prioritizing racial and ethnic diversity in clinical trials for therapies, diagnostics, and vaccines for COVID-19.

HR 1125 Expressing support for prioritizing racial and ethnic diversity in clinical trials for therapies, diagnostics, and vaccines for COVID 19

US Congress 116th Congress

Bill Texts

Introduced 09/19/2020

Weigh In


Sponsors (23)